XML 87 R74.htm IDEA: XBRL DOCUMENT v3.23.4
Segment reporting (Details)
$ in Millions
3 Months Ended
Nov. 30, 2023
USD ($)
segment
Nov. 30, 2022
USD ($)
Segment Reporting [Abstract]    
Number of reportable segments | segment 3  
Segment Reporting Information [Line Items]    
Sales $ 36,707 $ 33,382
Adjusted operating income (Non-GAAP measure) 687 1,014
Acquisition-related amortization (275) (330)
Acquisition-related costs (163) (39)
Transformational cost management (109) (138)
Certain legal and regulatory accruals and settlements (82) (6,554)
Adjustments to equity earnings in Cencora (50) (86)
LIFO provision (48) (18)
Operating loss (39) (6,151)
Reportable Segments | U.S. Retail Pharmacy    
Segment Reporting Information [Line Items]    
Sales 28,944 27,204
Adjusted operating income (Non-GAAP measure) 694 1,105
Reportable Segments | International    
Segment Reporting Information [Line Items]    
Sales 5,832 5,189
Adjusted operating income (Non-GAAP measure) 142 116
Reportable Segments | U.S. Healthcare    
Segment Reporting Information [Line Items]    
Sales 1,931 989
Adjusted operating income (Non-GAAP measure) (96) (152)
Corporate and Other    
Segment Reporting Information [Line Items]    
Adjusted operating income (Non-GAAP measure) $ (53) $ (56)